Elsevier introduces Cardiac Electrophysiology Clinics

Philadelphia, 27 April 2010 - Elsevier, the world-leading publisher of scientific, technical and medical information products and services, proudly announces a new addition to the Clinics of North America series – Cardiac Electrophysiology Clinics.

Under the expert guidance of Consulting Editors Dr. Ranjan Thakur and Dr. Andrea Natale, each issue is devoted to a single topic that covers the most significant concerns in this field. According to Dr. Thakur, the goal of Cardiac Electrophysiology Clinics is "to provide comprehensive reviews of contemporary issues of interest to clinicians. Electrophysiologists as well as other cardiologists and physicians caring for patients with arrhythmias will find these issues helpful in clinical decision making."

Dr. Thakur is Professor of Medicine and Program Director of the Cardiac Electrophysiology Fellowship at Michigan State University and Director of the Arrhythmia Service at the Thoracic and Cardiovascular Institute, Sparrow Health System, in Lansing, Michigan. Dr. Natale is Executive Medical Director of Texas Cardiac Arrhythmia Institute at St. David's Medical Center in Austin Texas.

The initial issues of this quarterly publication feature the following topics:

• Sudden Cardiac Death: Despite emergency medical response systems, long-term survival from out-of-hospital cardiac arrest remains poor in most US cities. This issue covers the full spectrum of issues related to sudden cardiac death, including the epidemiology of sudden cardiac death, advances in CPR, the implantable cardiac defibrillator (ICD), and ventricular tachycardia ablation.

• Epicardial Interventions in Electrophysiology: Epicardial ablation is a relatively new technique that is less invasive than traditional surgical ablation. It shows promise in certain patient populations. This issue of Cardiac Electrophysiology Clinics is one of the first collections of articles on this cutting edge technique.

• Advances in Arrhythmia Analyses: A Case-Based Approach: This issue is a valuable tool to help electrophysiologists interpret complex ECGs so they can better understand arrhythmia mechanisms. Organized by cases, this issue illustrates many of the classic electrocardiographic findings and phenomena that every electrophysiologist should know.

• Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Arrhythmogenic right ventricular dysplasia is an inherited heart muscle disorder that may cause abnormal electrical heart rhythms and weakening of the pumping action of the heart, resulting in sudden death. The electrocardiograph (EKG) is used to diagnose the disease, so it is important for cardiac electrophysiologists to be familiar with the disease and to be able to recognize it on the EKG.

• Advances in Antiarrhythmic Drug Therapy: Cardiac electrophysiologists have many options for treating arrhythmias, including catheter ablation and implantable cardiac defibrillators. Antiarrhythmic agents, which are pharmaceutical agents used to suppress fast rhythms of the heart (cardiac arrhythmias), represent another treatment option. This issue summarizes the most current thinking on the role of pharmaceuticals in relation to other types of treatment, helping electrophysiologists to determine the best method for managing their patients.

A personal subscription to Cardiac Electrophysiology Clinics includes full text online access to each issue as it publishes on Theclinics.com. Cardiac Electrophysiology Clinics is available online for institutions through MD Consult, Journals Consult and ScienceDirect. Visit booth #316 at Heart Rhythm 2010, May 13-15th, to learn more or visit cardiacep.theclinics.com.

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including the Lancet (www.thelancet.com) and Cell (www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com), Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and Nursing Consult (www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (www.scival.com) and MEDai's Pinpoint Review (www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading publisher and information provider. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).